Last reviewed · How we verify
Neurexan®
At a glance
| Generic name | Neurexan® |
|---|---|
| Also known as | Nx4 |
| Sponsor | Biologische Heilmittel Heel GmbH |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Neurexan - a Clinical Trial in Short-Term Insomnia Patients (PHASE2)
- Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands (PHASE2)
- Explorative Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting in Healthy Subjects (PHASE1, PHASE2)
- Explorative Open Label Study of Efficacy Profile of Neurexan® in Experimental Acute Stress Setting in Healthy Subjects (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Neurexan® CI brief — competitive landscape report
- Neurexan® updates RSS · CI watch RSS
- Biologische Heilmittel Heel GmbH portfolio CI